Yttrium-90 radiopharmaceutical for transarterial radioembolization

Yttrium-90 microspheres

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Yttrium-90 radiopharmaceutical for transarterial radioembolization, covering 2025-10-07 to 2025-10-07. Get the full timeline:

Most recent: Clinical Trial Update: Y-90 Treatment Response Using Transarterial Radioembolization [Phase 2]

See pricing